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REVIEW
Magnetic separation-based blood 
purification: a promising new approach for the 
removal of disease-causing compounds?
I K Herrmann1,2, A A Schlegel3, R Graf3, W J Stark4 and Beatrice Beck‑Schimmer1,2*
Abstract 
Recent studies report promising results regarding extracorporeal magnetic separation‑based blood purification for 
the rapid and selective removal of disease‑causing compounds from whole blood. High molecular weight com‑
pounds, bacteria and cells can be eliminated from blood within minutes, hence offering novel treatment strategies 
for the management of intoxications and blood stream infections. However, risks associated with incomplete particle 
separation and the biological consequences of particles entering circulation remain largely unclear. This article dis‑
cusses the promising future of magnetic separation‑based purification while keeping important safety considerations 
in mind.
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Background
The direct removal of disease-causing compounds is 
an inherently attractive treatment modality for a range 
of pathological conditions, including intoxications and 
blood stream infections [1]. While low molecular weight 
compounds (potassium, urea, etc.) are routinely removed 
from blood circulation by membrane-based processes, 
such as hemodialysis and hemofiltration [2], high molec-
ular weight targets are only accessible by sorption-based 
processes e.g. hemoadsorption and hemoperfusion, 
where blood is pushed at high flow rates through adsor-
bent cartridges. In spite of promising initial findings, the 
practical use of hemoperfusion is still controversial and 
concerns have been raised due to potential side effects 
such as unspecific protein adsorption, loss of blood cells 
(e.g. platelets) and possible activation of coagulation and 
inflammation pathways during operation. Compared 
to porous membranes, the use of free-floating nano-
sized particles exhibits significant benefits in terms of 
surface accessibility (no pore diffusion, shorter contact 
times), but this comes at a price: the pathogen-loaded 
particles need to be removed from the blood. Recently, 
it has been demonstrated that magnetic (nano-)particles 
can be employed to bind pathogenic substances on their 
surface, followed by a re-collection by magnetic separa-
tion. In magnetic separation-based blood purification, 
capturing agents attached to tiny magnetic nanoparticles 
are injected into an extracorporeal blood circuit (Fig. 1). 
They then form a complex consisting of the target com-
pounds attached to the magnetic particle which can be 
rapidly removed from blood by magnetic separation. The 
performance of such blood cleansing processes is essen-
tially determined by the target-ligand binding (binding 
site accessibility, specificity, contact time), the through-
put and, most critically, the efficiency of the magnetic 
separation process.
Review
Magnetic separation-based blood purification is espe-
cially attractive for the removal of high molecular weight 
compounds, which are poorly removed by conventional 
(diffusion-based) blood purifications systems (e.g. dialy-
sis, hemoadsorption) (Fig.  2) [2]. The small size, the 
high surface-to-volume ratio and the high mobility of 
nanoparticles allow short diffusion distances and hence 
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increased binding efficiencies even for high molecular 
weight compounds. A range of chemically diverse tar-
get compounds, including heavy metal ions (uranyl [3], 
lead [4–6] and cadmium ions [7], small molecule drugs 
(digoxin [5, 6, 8], diazepam [9]), proteins (cytokines [5, 
8]), bacteria and bacterial compounds [10] have been 
successfully removed ex  vivo from whole blood in the 
past decade (Table  1). However, such targeted com-
pound removal generally requires the use of magnetic 
beads with a pathogen-specific capturing agent and thus 
has been significantly limiting the future applicability of 
magnetic blood purification. Particularly, urgent medical 
situations, such as acute intoxications or blood stream 
infections where the disease-causing factor is unknown, 
remain challenging. In their recent study, Kang et al. [1] 
present a very promising capturing agent in scenarios of 
systemic infections that omits the necessity of first iden-
tifying the disease-causing factor. The mannose binding 
lectin (MBL) captures a wide range of pathogens (gram-
negative, gram-positive bacteria, and fungi) and allows 
rapid therapeutic intervention. This is particularly rele-
vant in sepsis patients, where identification of the causing 
Fig. 1 Principle of magnetic separation‑based blood purification: elimination of pathogens.
Fig. 2 Size and diffusivity of various biologically relevant target compounds for blood purification. The larger the size of the target compound, the 
smaller the diffusion coefficient. Magnetic blood purification may offer a promising alternative to diffusion‑based blood purification.
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microbe based on blood cultures typically takes 24–48 h 
(with a high rate of false negatives). As every hour in 
delayed treatment onset leads to an increased patient 
mortality of up to 9% [11], broad spectrum antibiotics are 
generally administered early. However, such overuse of 
antibiotics leads to antibiotic-resistant strains, increased 
costs and other important side effects. While magnetic 
capturing of circulating bacterial pathogens is very prom-
ising in the experimental setting [1], the impact on sur-
vival in human sepsis where bacterial loads in the blood 
are variable, and generally much lower than in animal 
models, remains to be investigated. 
When bringing magnetic blood purification processes 
closer to clinical evaluation, safety of operation becomes 
pivotal. Extracorporeal blood purification has been sug-
gested previously to provide a possible alternative to 
direct in  vivo application (injection) of magnetic nano-
particles and to prevent off-target accumulation of mag-
netic capturing agents (e.g. in the liver or lung). Recent 
studies have shown that the capturing efficiency of mag-
netic iron oxide nanoparticles is significantly decreased 
under clinically desirable blood flow rates, thereby poten-
tially compromising the procedure’s efficiency and safety 
[12]. Blood flow partition in front of the magnetic sepa-
rator has been suggested as a valid method to decrease 
the perfusion flow in the magnetic separator while keep-
ing the throughput at an acceptably high rate [1, 8]. We 
recently showed that ferromagnetic iron nanoparticles 
were retained at high efficiency under high flow rates 
and that magnetic bead concentration after the separator 
was below detection limit after a single pass [12]. How-
ever, ultra-sensitive particle detection in samples with 
high matrix complexity (e.g., blood, tissue) are urgently 
warranted as even state-of-the-art elemental analyti-
cal measurements (e.g., Inductively Coupled Plasma 
Mass Spectrometry) encounter significant limitations 
and reach detection limits in the order of >1 µg particles 
per gram of sample (where 1  g of particles corresponds 
to ~1018 single particles). Magnetic measurements for 
ultrasensitive magnetic nanoparticle detection are now 
increasingly being explored, which would allow detection 
of off-target accumulation of nanomaterial and biodeg-
radation of nanomaterials, which in turn could initiate 
acute and long-term effects such as tumorigenesis, fibro-
sis and toxic effects.
Other important safety aspects include non-specific 
adsorption of blood constituents (coagulation and com-
plement factors, cells, etc.) as well as activation of inflam-
matory reactions in the blood compartment [13]. Such 
possible side effects have to be evaluated in detail and 
ruled out before this new operation is translated into a 
clinical scenario.
Unfortunately, there is an ever growing disequilibrium 
between manuscripts reporting on the synthesis of new 
nanomaterials and their promising applications and stud-
ies actually performing comprehensive risk evaluation of 
the synthesized materials [14]. At present, risk analysis 
using relevant exposure conditions remains to be the bot-
tle neck when translating promising nanomaterial-based 
approaches. Hence, it is of major importance to establish 
strategies to gain insight into the potential risks—both 
short-term and long-term—associated with magnetic 
blood purification and, to balance risks adequately with 
therapeutic benefits.
Conclusions
In summary, extracorporeal magnetic separation-based 
blood purification is a promising strategy to rapidly and 
selectively remove high molecular weight compounds 
from blood. The technique has been successfully 
Table 1 Compound removed from whole blood by magnetic separation-based blood purification
Compound removed from whole blood Model Publication
Uranyl ions In vitro Wang et al. [3]
Lead ions In vitro Lee et al. [4]
Herrmann et al. [5]
In vivo (rat) Herrmann et al. [6]
Cadmium ions In vitro Jin et al. [7]
Digoxin In vitro Herrmann et al. [5]
Herrmann et al. [8]
In vivo (rat) Herrmann et al. [6]
Diazepam In vitro Cai et al. [9]
Interleukin‑6 (IL‑6) In vitro Herrmann et al. [5]
Interleukin‑1β (IL‑1β) In vitro Herrmann et al. [8]
Lipopolysaccharide (LPS), Escherichia coli In vitro Herrmann et al. [10]
Endotoxins, gram‑negative and gram‑positive bacteria, fungi In vitro and in vivo (rat) Kang et al. [1]
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evaluated in  vivo in experimental settings investigating 
the clinically relevant scenarios of intoxication and sepsis 
in rat models [1]. However, for translation, ultra-sensitive 
particle detection systems and risk evaluation strategies 
are needed in order to better understand relevant expo-
sure scenarios and the therewith associated benefit-risk 
ratio. Once safety issues have been ruled out, magnetic 
separation-based blood purification may become an 
attractive treatment modality enabling rapid removal of 
poorly accessible high molecular weight disease-causing 
compounds from blood, potentially bridging the time to 
run diagnostic tests and establish a suitable therapy.
Abbreviation
MBL: mannose binding lectin.
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